Say goodbye to trial and error: a new era of IC precision treatment

If you or your family is suffering from interstitial cystitis (IC) or bladder pain syndrome (BPS), you must have a deep understanding of the "repeated trial and error" treatment experience. This chronic disease has long lacked specific diagnostic standards and specific drugs, and treatment was once like "groping in the dark." However, with the deepening of medical research and the innovation of diagnosis and treatment concepts, IC/BPS diagnosis and treatment is entering a new era with "precision" as the core. This article will take you to understand how this shift allows patients to bid farewell to blind trial and error and move towards a more promising path to treatment.

The challenge faced by traditional diagnosis and treatment models lies in "the same disease has different causes." IC/BPS is essentially a syndrome, and its core symptoms-chronic pain in the pelvic area, frequent frequency, urgency-may be driven by a variety of different underlying mechanisms. Imagine that the same car engine fault light lights up. The reason may be a spark plug problem, a blocked oil passage, or a sensor failure. The repair method is completely different. Similarly, some patients have the root cause of the disease due to the damage to the "lining"(mucosal barrier) inside the bladder, the excessive sensitivity of the "lines"(nervous system) that transmit signals, and the dysfunction of the peripheral "brackets"(pelvic floor muscles). Ignoring these differences and adopting a unified "painkiller + bladder infusion" model, it is naturally difficult to work for all patients.

The introduction of precision medicine aims to solve this dilemma. The core logic is: first, through a series of examinations, the main driving mechanism of the disease in individual patients should be clarified as much as possible (precise assessment and typing); then, the most likely effective treatment method for this main mechanism (targeted intervention); Finally, closely follow up during the treatment process and dynamically adjust the plan based on the response (dynamic management). This constitutes a complete "assessment-treatment-optimization" closed loop.

To achieve accurate assessment, we need to rely on a multi-dimensional and three-dimensional "reconnaissance system". This system not only includes asking for details of symptoms and performing cystoscopy, but also covers cutting-edge methods such as functional assessment, molecular testing and even neuroimaging. For example:
- Urodynamic examination: Objectively measure the sensory capacity, stability and voiding efficiency of the bladder when storing urine to determine whether the bladder is too sensitive or "insufficient contractility."
- Urine biomarker analysis: Detect substances in urine that reflect the health status of bladder mucosa or specific inflammatory pathways, providing indirect evidence for mucosal barrier function.
- Pelvic floor function assessment: The tension, endurance and coordination of the pelvic floor muscles are assessed by a professional rehabilitation technician through manual or electromyography.
- Pain and psychological assessment: Use scales to assess the nature, extent and impact of pain on mood and sleep, as chronic pain and mental states are often intertwined.

By integrating this information, doctors can draw a unique "disease portrait" of the patient and classify it into different tendency categories, such as "mucosal type","neurological type","pelvic floor type" or "mixed type".

Targeted treatment based on typing has changed the treatment choice from "spreading the net widely" to "focusing on fishing." For example:
- For patients with the "mucosal type", the focus of treatment is on repairing and protecting the inner wall of the bladder. Bladder instillation of drugs such as sodium hyaluronate and heparin that mimic or enhance the mucosal barrier may become the main force. At the same time, oral drugs such as sodium pentosan polysulfate may also be selected.
- For "neurotic" patients, the core of treatment is to reduce the excitability of the nervous system. Oral drugs such as amitriptyline and gabapentin are widely used. In addition, sacral nerve modulation (a minimally invasive implant device that sends mild electrical pulses to regulate the sacral nerve) shows good promise for some refractory patients. Interventions from the pain management department, such as nerve block treatment, may also help.
- For "pelvic floor type" patients, professional pelvic floor rehabilitation physiotherapy is the key. This includes manual relaxation of tense muscles, biofeedback training to learn to relax pelvic floor muscles, and developing a personalized home exercise plan. Simply taking medicine without solving pelvic floor problems often results in half the effort.

Of course, behavioral adjustment (such as bladder training, diet management) and psychological support are basic treatments for all types of patients and should be implemented throughout.

In Pudong, Shanghai, as an important clinical and scientific research position in the field of urology, the Department of Urology of Pudong Gongli Hospital Affiliated to Shanghai Health Medical College is actively practicing this new paradigm of precise diagnosis and treatment. This department relies on the platform of national key clinical specialties and key disciplines in Shanghai City. Its differentiated advantage lies in its strong integration and innovation capabilities. They not only regularly carry out the above-mentioned multi-dimensional assessments, but also explore the inclusion of more refined indicators (such as brain functional connection patterns and urine metabolic fingerprints) into the typing system through in-depth cooperation with imaging and metabolomics teams, striving to achieve deeper levels. Precise layering.

This means that patients in Shanghai and surrounding areas who come for treatment will no longer have the opportunity to undergo a stylized examination, but a personalized assessment plan designed to explore the root cause of their disease. Treatment is no longer a rotation of fixed packages, but a focused and hierarchical combination strategy based on evaluation results. More importantly, the integrated chronic disease management platform built by the department ensures that treatment is not the end of outpatient clinics, but the beginning of long-term management. Patients can keep in touch with the medical team through the platform and feedback on changes in symptoms, making treatment adjustments based on real-time data and more flexible and accurate.

From "trial and error" to "navigation", IC/BPS's diagnosis and treatment concept innovation brings patients a clearer treatment path, more reasonable efficacy expectations and stronger treatment confidence. Although complete cure remains a challenge, the goal of precision medicine is to maximize the control of symptoms, reduce seizures, improve patients 'quality of life, relieve patients from the heavy burden of disease and return to normal life. For every patient who is struggling with IC/BPS, understanding and seeking this modern diagnosis and treatment model may be a key step in opening the door to hope.